This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alan Wile, MD; Michael Smolin, MD

Arch Surg. 1987;122(11):1321-1325.

Abstract
• Hyperthermic isolation-perfusion (I-P) was used to treat 27 patients with refractory pelvic cancer. All patients except one achieved pelvic isolation as manifested by selective pelvic heating and by pharmacologic monitoring. Patient response was good, with rapid pain relief in 75% and tumor control as detected by physical examination, computed tomographic scan, and decline in carcinoembryonic antigen levels. Pelvic drug exposure averaged 7.8 times that of systemic drug exposure. Of the 20 patients with recurrent rectal adenocarcinoma, one complete response (duration, eight months), seven partial responses (average duration, 10 months), four patients with stable disease (average duration, 12 months), and five with disease progression were observed. Three patients could not be evaluated due to late deaths as a consequence of their disease. There were two postoperative deaths in the remaining seven patients, one due to drug toxicity and one due to probable cardiac arrhythmia. Pelvic I-P has evolved with the avoidance of laparotomy and increased drug dose. We conclude that hyperthermic I-P for pelvic cancer is a safe, effective procedure and an excellent therapeutic option for patients with persistent pelvic cancer.

(Arch Surg 1987; 122:1321-1325)

Author Affiliations
From the Departments of Surgery (Dr Wile) and Radiology (Dr Smolin), University of California Irvine Medical Center, Orange.

Footnotes
Accepted for publication Aug 4, 1987.

Read before the Annual Meeting of the Society of Surgical Oncology, London, April 29, 1987.

Reprint requests to Division of Surgical Oncology, Department of Surgery, University of California Irvine Medical Center, 101 City Dr South, Orange, CA 92668 (Dr Wile).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hypoxic Pelvic Perfusion With Mitomycin C Using a Simplified Balloon-Occlusion Technique in the Treatment of Patients With Unresectable Locally Recurrent Rectal Cancer
Guadagni et al.
Arch Surg 2001;136:105-112.
ABSTRACT | FULL TEXT  

Isolated Pelvic Perfusion for Unresectable Cancer Using a Balloon Occlusion Technique
Turk et al.
Arch Surg 1993;128:533-539.
ABSTRACT